A Day in the Life of Pathsensors CEO, Ted Olsen

The Maryland Biotech industry is made up a whole range of biotech companies beyond medical technologies and therapeutics. PathSensors is one of those companies.

This Baltimore-based, commercial biotech company provides high-speed, high-sensitivity pathogen detection and threat prevention solutions through three proprietary platforms. Their CANARY technology, licensed from MIT, is regarded as one of the most advanced solutions available, in terms of sensitivity and speed of detection.

PathSensors works with high profile clients like the Pentagon, banks, Fortune 500 corporations, government agencies, agricultural organizations, food producers, and more to detect a wide-variety of deadly pathogens in order to stop outbreaks before they spread.

Aside from being a respected innovator and executive in the detection industry, PathSensors CEO, Ted Olsen, is a highly visible leader in the regional biotech community, serving on the Governors Life Science Advisory Board since 2016 and a vocal advocate for the growing ecosystem.

PathSensors has given us a snapshot of what a day in the life of Mr. Olsen is like running a successful commercial biotech company.

For more on PathSensors visit them at https://pathsensors.com

The following two tabs change content below.

• Bio
• Latest Posts

Chris Frew

President, CEO at Biobuzz Media & Workforce Genetics

Over the past 8 years, Chris has grown BioBuzz into a respected brand that is recognized for its community building, networking events and news stories about the local biotech industry. In addition, he runs a Recruiting and Marketing Agency that helps companies attract top talent through a blended model that combines employer branding and marketing services together with a high powered recruiting solution.

Latest posts by Chris Frew (see all)

• Maryland Startup Developing AI-Enabled Drug Discovery Technology, Insilico Medicine, Just Raised $37M in Funding from Leading Chinese VC Firm - September 10, 2019
• Welldoc Welcomes Dan Medin, VP of Market Solution to the Team. - September 5, 2019
• A Uniquely Positioned GMP BioManufacturing Facility Hits the Market in Maryland - September 3, 2019